Ditchcarbon
  • Customers
  1. Organizations
  2. Diasorin
Public Profile
Pharmaceutical Preparation Manufacturing
IT
updated 9 days ago

Diasorin

Company website

DiaSorin S.p.A., headquartered in Italy, is a prominent player in the global diagnostics industry, specialising in the development and production of innovative diagnostic solutions. Founded in 1968, the company has established a strong presence in major operational regions, including Europe, North America, and Asia. With a focus on immunodiagnostics and molecular diagnostics, DiaSorin offers a range of unique products, including its LIAISON® and Simplexa™ platforms, which are renowned for their accuracy and efficiency. The company has achieved significant milestones, such as expanding its product portfolio and enhancing its technological capabilities, solidifying its market position as a leader in the field. Recognised for its commitment to quality and innovation, DiaSorin continues to advance healthcare diagnostics, making a meaningful impact on patient care worldwide.

DitchCarbon Score

How does Diasorin's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

41

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

29

Industry Benchmark

Diasorin's score of 41 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.

64%

Let us know if this data was useful to you

Diasorin's reported carbon emissions

In 2024, Diasorin reported total carbon emissions of approximately 248,000 kg CO2e, comprising 80,000 kg CO2e from Scope 1, 16,000 kg CO2e from Scope 2, and 151,000 kg CO2e from Scope 3 emissions. This data reflects a commitment to transparency in their environmental impact, with emissions data inherited from their parent company, DiaSorin S.p.A. In 2023, Diasorin's emissions were higher, totalling about 374,000 kg CO2e, with 85,000 kg CO2e from Scope 1, 18,000 kg CO2e from Scope 2, and 272,000 kg CO2e from Scope 3. The company has set a long-term goal to achieve Net Zero emissions by 2050, starting from 2023, which encompasses all scopes of emissions. The company is actively working towards reducing its carbon footprint and has outlined its climate commitments in its sustainability reports. These initiatives are part of a broader strategy to align with global climate goals and demonstrate corporate responsibility in addressing climate change.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2016201820192020202120222023
Scope 1
3,223,720
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 2
8,426,130
00,000,000
00,000,000
0,000,000
00,000,000
00,000,000
00,000,000
Scope 3
-
-
-
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Diasorin's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Diasorin is in IT, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Diasorin is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Bio-Techne

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Guangzhou Wondfo Biotech Co.,Ltd

CN
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 21 days ago

bioMérieux, Inc.

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 3 days ago

Sartorius

DE
•
Medical, precision and optical instruments, watches and clocks (33)
Updated about 2 hours ago

F. Hoffmann-La Roche AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Genomic Health, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250917.4
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy